Cell BioEngines Raises $2M for Expansion and R&D in Stem Cell Therapies

Cell BioEngines raises $2M in Funding

Cell BioEngines (Linkedin), a stem cell research company, has secured an additional $2M in funding to advance their allogeneic 'off-the-shelf' stem cell-derived therapies for hematological cancer patients. They are seeking partnerships with research institutions, medical centers, and regulatory experts to further develop and evaluate the efficacy and safety of their innovative treatments.

Funding Amount: $2 million

Industry: Biotechnology Research

Employee Count: 2-10

CEO: Ajay V. (CEO Linkedin)

What Cell BioEngines needs to buy: Companies specializing in stem cell research, clinical trial support, and regulatory compliance services are ideal partners for Cell BioEngines. These collaborations will help accelerate the development and approval of their stem cell therapies, ultimately providing a new treatment option for hematological cancer patients in need.